| Autor: |
McCarroll MN; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA., Gendelev L; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA., Kinser R; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA., Taylor J; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA., Bruni G; Cardiovascular Research Center and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.; Department of Systems Biology, Harvard Medical School, 149 13th Street, Charlestown, MA, 02129, USA., Myers-Turnbull D; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA., Helsell C; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA., Carbajal A; Department of Biology, San Francisco State University, San Francisco, CA, USA., Rinaldi C; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA., Kang HJ; Department of Pharmacology and NIMH Psychoactive Drug Screening Program, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, 27759, USA., Gong JH; Department of Chemistry, Brown University, Providence, RI, 02912, USA., Sello JK; Department of Chemistry, Brown University, Providence, RI, 02912, USA., Tomita S; Department of Cellular and Molecular Physiology, Department of Neuroscience, Yale University School of Medicine, New Haven, CT, 06510, USA., Peterson RT; Cardiovascular Research Center and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 02129, USA.; Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, 84112, USA., Keiser MJ; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA. keiser@keiserlab.org.; Departments of Pharmaceutical Chemistry and of Bioengineering & Therapeutic Sciences, University of California, San Francisco, CA, 94158, USA. keiser@keiserlab.org., Kokel D; Institute for Neurodegenerative Diseases, University of California, San Francisco, CA, 94143, USA. david.kokel@ucsf.edu.; Department of Physiology, University of California, San Francisco, CA, 94158, USA. david.kokel@ucsf.edu. |
